12th March 2012 -- Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, recently enhanced their web based randomization system WebEZ™, and are relauching the product under the new name, aXcess™. aXcess™ includes similar features along with enhanced functionality to improve the user experience. Like WebEZ™, aXcess™ is fully configurable, can be set up very quickly, and is cost effective. Almac’s new state of the art IVR/IWR system includes key new features such as language capabilities and data integration.
aXcess™ provides a unique alternative to using paper based or manual systems to automate patient randomization and supply chain management for small to mid sized studies. Almac’s intuitive and user-friendly aXcess™ system gives clients the full benefit of a web-based randomization system, including state of the art reporting functionalities, shorter timelines for system build, and a price point to fit tight study budgets.
“The new IVR/IWR system, aXcess™, coupled with our clinical packaging and distribution bundle gives companies who would typically utilize a paper based approach to randomization and supply chain management an alternative option. This option more effectively manages the trials our clients are conducting at a cost that works within their budgetary restrictions”, says Donna Christopher, VP of Operations.
This recently enhanced IVR/IWR system was developed to give our clients the features and functionalities they are looking for in a web-based system for the small to mid-sized studies they are conducting.
For further information on aXcess™ or to request a demo please click here.
The Almac Group provides a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, and IXRS® technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.
The company employs over 3,300 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California.